Comprehensive evaluation of mapping complex traits in wheat using genome-wide association studies.
Dinesh K SainiYuvraj ChopraJagmohan SinghKaransher S SandhuAnand KumarSumandeep BazzerPuja SrivastavaPublished in: Molecular breeding : new strategies in plant improvement (2021)
Genome-wide association studies (GWAS) are effectively applied to detect the marker trait associations (MTAs) using whole genome-wide variants for complex quantitative traits in different crop species. GWAS has been applied in wheat for different quality, biotic and abiotic stresses, and agronomic and yield-related traits. Predictions for marker-trait associations are controlled with the development of better statistical models taking population structure and familial relatedness into account. In this review, we have provided a detailed overview of the importance of association mapping, population design, high-throughput genotyping and phenotyping platforms, advancements in statistical models and multiple threshold comparisons, and recent GWA studies conducted in wheat. The information about MTAs utilized for gene characterization and adopted in breeding programs is also provided. In the literature that we surveyed, as many as 86,122 wheat lines have been studied under various GWA studies reporting 46,940 loci. However, further utilization of these is largely limited. The future breakthroughs in area of genomic selection, multi-omics-based approaches, machine, and deep learning models in wheat breeding after exploring the complex genetic structure with the GWAS are also discussed. This is a most comprehensive study of a large number of reports on wheat GWAS and gives a comparison and timeline of technological developments in this area. This will be useful to new researchers or groups who wish to invest in GWAS.
Keyphrases
- genome wide
- copy number
- genome wide association
- dna methylation
- high throughput
- deep learning
- case control
- high resolution
- emergency department
- genome wide association study
- systematic review
- climate change
- single cell
- adverse drug
- mass spectrometry
- early onset
- artificial intelligence
- gene expression
- machine learning